Triptolide suppresses alkali burn ‐induced corneal angiogenesis along with a downregulation of VEGFA and VEGFC expression
In conclusion, topical TPL as a pharmacological agent has the ability to reduce angiogenesis in cornea and may have clinical indications for the treatment of corneal angiogenesis diseases which have to be further explored. This article is protected by copyright. All rights reserved.
Source: The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology - Category: Molecular Biology Authors: Geng Wang, Na Li, Xiaohong Lv, Naila Ahmed, Xinlei Li, Huidong Liu, Jing Ma, Yafang Zhang Tags: Full Length Article Source Type: research
More News: Biology | Burns | Cancer | Cancer & Oncology | Chemistry | Complementary Medicine | Herbs | Molecular Biology | Study | Thunder God Vine